Heemin Kang
고려대학교 신소재공학부 · 의학
Heemin Kang 교수의 연구실은 나노의학과 생체재료를 기반으로 한 혁신적 치료 및 진단 기술 개발에 초점을 맞추고 있습니다. 특히, 외소포체 기반 치료, 자기장 및 외부 자극을 활용한 세포 부착 조절, 그리고 정밀 나노입자를 활용한 진단·치료 통합 플랫폼(theranostics) 개발이 핵심 연구 방향입니다. 생체 환경에서의 세포 반응을 정밀하게 조절하고자 하는 목표 아래, 나노소재와 생체모방 재료의 응용을 지속적으로 탐색하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Extracellular vesicles (e.g., exosomes) carrying various biomolecules (e.g., proteins, lipids, and nucleic acids) have rapidly emerged as promising platforms for many biomedical applications. Despite their enormous potential, their heterogeneity in surfaces and sizes, the high complexity of cargo biomolecules, and the inefficient uptake by recipient cells remain critical barriers for their theranostic applications. To address these critical issues, multifunctional nanomaterials, such as magnetic
Cellular adhesion is regulated by the dynamic ligation process of surface receptors, such as integrin, to adhesive motifs, such as Arg-Gly-Asp (RGD). Remote control of adhesive ligand presentation using external stimuli is an appealing strategy for the temporal regulation of cell-implant interactions in vivo and was recently demonstrated using photochemical reaction. However, the limited tissue penetration of light potentially hampers the widespread applications of this method in vivo. Here, we
In the biological microenvironment, cells are surrounded by an extracellular matrix (ECM), with which they dynamically interact during various biological processes. Specifically, the physical and chemical properties of the ECM work cooperatively to influence the behavior and fate of cells directly and indirectly, which invokes various physiological responses in the body. Hence, efficient strategies to modulate cellular responses for a specific purpose have become important for various scientific
Nanotechnology is a fledgling field in cancer research, forging new opportunities to design and develop highly effective targeted therapies. By harnessing the unique properties of engineered precision nanoparticles (NPs), an arena of dual-purpose approach in nanomedicine called theranostics has emerged. Theranostics is a potential platform that integrates diagnosis and therapy within one nanosystem . For this system of approach, the tunability of engineered precision NPs and the potential to int
We investigated the differences in quantity and quality of skeletal muscle between metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) individuals using abdominal CT. One hundred and seventy-two people with morbid obesity who underwent bariatric surgery and 64 healthy control individuals participated in this retrospective study. We divided the people with morbid obesity into an MHO and MUO group. In addition, nonobese metabolic healthy people were included analysis to provi
Stenosis of the central veins is a common complication in hemodialysis patients. However, cerebral venous hypertension and neurological symptoms caused by central vein stenosis are relatively rare. We present a rare case of cerebral venous hypertension in a 63-year-old male who showed venous reflux into the dural sinuses due to central venous stenosis on time-of-flight MR angiography. After management for central venous stenosis, the venous reflux disappeared.
Neuromodulation is a highly promising technology for controlling neural circuits, treating nervous system diseases, and manipulating brain function. Conventional approaches, such as direct electrical stimulation or optogenetics, face challenges from their unstable therapeutic outcomes, invasive nature, and potential tissue damage. The emergence of stimuli-responsive nanomaterial-based wireless neuromodulation techniques offers tunability, minimal invasiveness, highly specific targeting, and long
Intracranial dural arteriovenous fistula (DAVF) is an abnormal arteriovenous shunt accounting for approximately 10%-15% of all intracranial vascular malformations. Most intracranial DAVFs are solitary, but multiple lesions at different sites can rarely occur. Most intracranial multiple DAVFs are synchronous types, whereas metachronous lesions are relatively uncommon. Herein, we report a rare case of metachronous DAVF occurring after the embolization of a preceding lesion in a 75-year-old female.